RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • U.S. prescription drug spending jumps to record $374 billion

    U.S. prescription drug spending jumps to record $374 billion
    U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Spending rose 13 percent, the...
  • Antidepressants: a deadly treatment?

    Antidepressants: a deadly treatment?
    The crash of Germanwings Flight 9525, allegedly the intentional act of co-pilot Andreas Lubitz, and the deaths of all 150 people on board is indeed a tragedy. But some good may come out of it if it induces people to take another look at those substances...
  • Mylan offers about $29B for rival generic drugmaker Perrigo

    In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion. Shares of both companies climbed to all-time highs on the news. If they combine, Mylan...
  • Mylan makes bid for Irish drugmaker Perrigo for $29 billion

    Generic drugmaker Mylan has made a bid to buy the Dublin-based drugmaker Perrigo Co. in a deal valued at about $29 billion. Mylan offered $205 per share in cash and stock. The offer was contained in a letter delivered to Perrigo CEO Joseph Papa on Monday...
  • Actavis: No apologies for seeking Alzheimer's drug profits

    A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits. Attorney Lisa Blatt told...
  • Horizon Pharma buying Hyperion for about $1.1 billion

    Irish firm Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders. Dublin-based Horizon Pharma said Monday that it would pay $46 a share for the Brisbane, Calif., company, marking a 5.6%...
  • GNC allowed to sell herbal brand under deal with N.Y. attorney general

    GNC allowed to sell herbal brand under deal with N.Y. attorney general
    Nutritional supplement retailer GNC Holdings Inc. is cleared to sell some of its most popular products, including echinacea, ginseng and St. John’s Wort, under an agreement announced Monday with New York’s attorney general. State...
  • UnitedHealth buys pharmacy-benefit manager Catamaran for $13B

    MINNEAPOLIS UnitedHealth Group Inc. is getting much bigger with a $12.8 billion deal to expand its prescription-drug benefit management business. UnitedHealth's stand-alone pharmacy-benefit management unit, OptumRx, announced Monday morning that it is...
  • FDA: Hospira's corrective actions at Italy plant weren't enough

     FDA: Hospira's corrective actions at Italy plant weren't enough
    The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing. The FDA in a March 31 letter said Hospira lacked written...
  • Hospira gets new FDA warning over facility in Italy

    Drug and medical device maker Hospira said Tuesday that it received a warning letter from the Food and Drug Administration following an inspection at a company factory in Italy. The company has received five warnings from the FDA in less than two years....
  • FDA questions evidence for lower-risk tobacco product

    U.S. health regulators have questions about the data submitted by tobacco maker Swedish Match in its bid to become the first company to market a smokeless tobacco product as less harmful than cigarettes. Food and Drug Administration scientists say they...